A detailed history of Massachusetts Financial Services CO transactions in Pfizer Inc stock. As of the latest transaction made, Massachusetts Financial Services CO holds 69,552,447 shares of PFE stock, worth $1.99 Billion. This represents 0.6% of its overall portfolio holdings.

Number of Shares
69,552,447
Previous 68,506,441 1.53%
Holding current value
$1.99 Billion
Previous $1.97 Billion 2.14%
% of portfolio
0.6%
Previous 0.66%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $27.1 Million - $31.1 Million
1,046,006 Added 1.53%
69,552,447 $1.93 Billion
Q4 2023

Feb 08, 2024

BUY
$26.13 - $33.94 $217 Million - $282 Million
8,298,920 Added 13.78%
68,506,441 $1.97 Billion
Q3 2023

Nov 08, 2023

BUY
$32.09 - $37.51 $166 Million - $195 Million
5,185,453 Added 9.42%
60,207,521 $2 Billion
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $35.6 Million - $41.2 Million
984,908 Added 1.82%
55,022,068 $2.02 Billion
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $187 Million - $244 Million
4,754,795 Added 9.65%
54,037,160 $2.2 Billion
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $331 Million - $433 Million
7,938,347 Added 19.2%
49,282,365 $2.53 Billion
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $40 Million - $48.8 Million
-913,582 Reduced 2.16%
41,344,018 $1.81 Billion
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $52.7 Million - $62.5 Million
-1,133,519 Reduced 2.61%
42,257,600 $2.22 Billion
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $436 Million - $541 Million
9,537,621 Added 28.17%
43,391,119 $2.25 Billion
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $4.52 Million - $6.7 Million
-109,340 Reduced 0.32%
33,853,498 $2 Billion
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $13.4 Million - $17.2 Million
-341,198 Reduced 0.99%
33,962,838 $1.46 Billion
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $35.8 Million - $40.5 Million
-996,075 Reduced 2.82%
34,304,036 $1.34 Billion
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $13.3 Million - $15 Million
-396,070 Reduced 1.11%
35,300,111 $1.28 Billion
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $83.2 Million - $106 Million
-2,486,876 Reduced 6.51%
35,696,181 $1.31 Billion
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $44.7 Million - $52.5 Million
-1,408,698 Reduced 3.56%
38,183,057 $1.4 Billion
Q2 2020

Aug 11, 2020

BUY
$30.12 - $36.54 $11.8 Million - $14.3 Million
391,828 Added 1.0%
39,591,755 $1.29 Billion
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $341 Million - $487 Million
-12,621,622 Reduced 24.36%
39,199,927 $1.28 Billion
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $106 Million - $121 Million
-3,229,409 Reduced 5.87%
51,821,549 $2.03 Billion
Q3 2019

Nov 05, 2019

SELL
$32.49 - $42.13 $20 Million - $25.9 Million
-615,374 Reduced 1.11%
55,050,958 $1.98 Billion
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $39.6 Million - $44.4 Million
-1,070,280 Reduced 1.89%
55,666,332 $2.41 Billion
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $16.6 Million - $18.2 Million
442,676 Added 0.79%
56,736,612 $2.41 Billion
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $148 Million - $168 Million
-3,839,508 Reduced 6.38%
56,293,936 $2.46 Billion
Q3 2018

Oct 25, 2018

SELL
$34.47 - $41.81 $60.2 Million - $73.1 Million
-1,747,836 Reduced 2.82%
60,133,444 $2.65 Billion
Q2 2018

Jul 30, 2018

BUY
$32.98 - $35.16 $5.3 Million - $5.65 Million
160,730 Added 0.26%
61,881,280 $2.25 Billion
Q1 2018

May 04, 2018

BUY
$31.91 - $37.02 $28.4 Million - $32.9 Million
889,094 Added 1.46%
61,720,550 $2.19 Billion
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $27.7 Million - $29.3 Million
-831,644 Reduced 1.35%
60,831,456 $2.2 Billion
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $114 Million - $125 Million
3,663,532 Added 6.32%
61,663,100 $2.2 Billion
Q2 2017

Aug 14, 2017

BUY
N/A
57,999,568
57,999,568 $1.95 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $161B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.